# Carboplatin

## Paraplatin inj 150mg/15mL

| 藥物代碼 | IPAR |
| :--- | :--- |
| 適應症 | Ovarian cancer, advanced: Initial treatment of advanced ovarian cancer in combination with other established chemotherapy agents; palliative treatment of recurrent ovarian cancer after prior chemotherapy, including cisplatin-based treatment. |
| 副作用 | Myelosuppression especially thrombocytopenia, leukopenia; nausea & vomiting, abdominal pain, diarrhea, constipation; nephrotoxicity; neurotoxicity including paresthesia & decreased deep tendon reflexes; transient visual disturbances, ototoxicity manifesting as tinnitus; abnormal liver function tests; hypersensitivity reactions. |
| 禁忌 | History of severe allergic reaction to carboplatin, cisplatin, other platinum-containing formulations, mannitol, or any component of the formulation; should not be used in patients with severe bone marrow depression or significant bleeding. |
| 懷孕用藥危分級 | 儘量避免 |
| 孕期用藥建議 | Contraindicated - 1st trimester |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | PARAPLATIN 通常輸注15 分鐘以上 |
| 注意事項 | 1. 室溫，配製後安定性室溫8小時 2. 不可使用含鋁針頭或可能與藥品接觸部位含鋁的靜脈給藥器組。 |

